[Anticoagulation in stroke. Evidence-based and empirical indications]

MeSH terms

• Administration, Oral
• Adult
• Age Factors
• Aged
• Aged, 80 and over
• Anticoagulants / administration & dosage
• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use*
• Atrial Fibrillation / complications
• Atrial Fibrillation / drug therapy
• Clinical Trials as Topic
• Contraindications
• Female
• Heart Valve Prosthesis Implantation
• Hemorrhage / chemically induced
• Heparin / administration & dosage
• Heparin / therapeutic use
• Heparin, Low-Molecular-Weight / administration & dosage
• Heparin, Low-Molecular-Weight / therapeutic use
• Heparinoids / administration & dosage
• Heparinoids / therapeutic use
• Humans
• Male
• Meta-Analysis as Topic
• Middle Aged
• Myocardial Infarction / complications
• Myocardial Infarction / drug therapy
• Partial Thromboplastin Time
• Placebos
• Platelet Aggregation Inhibitors / administration & dosage
• Platelet Aggregation Inhibitors / therapeutic use
• Primary Prevention
• Randomized Controlled Trials as Topic
• Recurrence
• Risk Factors
• Sex Factors
• Stroke / blood
• Stroke / drug therapy*
• Stroke / physiopathology
• Stroke / prevention & control